4D制药ADR吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
231 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-06 02:46
252 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-30 02:46
207 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-25 05:35
212 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-24 21:38
210 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-02 06:44
282 0 公告 Notice of Effectiveness 4D制药ADR资讯 04-29 18:47
221 0 公告 [Cover]Correspondence 4D制药ADR资讯 04-26 00:00
220 0 公告 [Cover]SEC-generated letter 4D制药ADR资讯 04-26 00:00
347 0 公告 Registration statement by foreign private issuers 4D制药ADR资讯 04-22 04:39
433 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-05 00:44
381 0 公告 Securities to be offered to employees in employee 4D制药ADR资讯 04-02 05:26
386 0 公告 Annual and transition report of foreign private is 4D制药ADR资讯 04-01 05:55
341 0 公告 Notice of Effectiveness 4D制药ADR资讯 03-31 19:09
368 0 公告 [Amend] Registration statement by foreign private 4D制药ADR资讯 03-29 05:50
307 0 公告 [Cover]Correspondence 4D制药ADR资讯 03-28 00:00
591 1 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 03-23 23:13
427 0 公告 Registration statement by foreign private issuers 4D制药ADR资讯 03-09 06:32
387 0 公告 [Amend] Statement of acquisition of beneficial own 4D制药ADR资讯 03-03 07:58
428 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 03-01 06:44
414 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 02-26 07:33
434 0 公告 [Amend] Report of foreign issuer [Rules 13a-16 and 4D制药ADR资讯 02-19 06:34
463 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-19 06:26
408 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-19 06:26
398 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 02-18 21:29
447 0 公告 [Amend] Statement of acquisition of beneficial own 4D制药ADR资讯 02-03 23:51
502 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 02-03 07:02
507 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 02-03 05:05
433 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 01-11 05:00
434 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 01-11 05:00
393 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 01-06 05:15
475 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 12-15 00:46
458 0 公告 Notice of Effectiveness 4D制药ADR资讯 10-15 18:50
410 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 10-15 05:15
539 0 公告 [Amend] Registration statement for certain foreign 4D制药ADR资讯 10-07 18:26
511 0 公告 Post-Effective amendments for registration stateme 4D制药ADR资讯 10-01 18:51
491 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 10-01 18:42
481 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 10-01 18:31
504 0 公告 Notice of Effectiveness 4D制药ADR资讯 10-01 00:00
534 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 09-30 18:44
499 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 09-24 05:07
633 0 公告 Registration statement for certain foreign private 4D制药ADR资讯 09-14 19:32
467 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 08-12 03:47
564 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 08-02 23:41
593 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-28 05:48
468 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 07-28 04:50
792 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-08 00:29
517 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-05 04:17
487 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 05-26 02:36
475 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 05-26 02:17
546 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 05-25 21:10
512 0 公告 Notice of Effectiveness 4D制药ADR资讯 05-25 18:38
536 0 公告 Securities to be offered to employees in employee 4D制药ADR资讯 05-01 06:14
533 0 公告 [Amend] Annual and transition report of foreign pr 4D制药ADR资讯 05-01 05:39
566 0 公告 Registration statement for certain foreign private 4D制药ADR资讯 04-24 04:27
520 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-19 18:17
553 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-19 18:17
530 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 04-12 18:19
568 0 公告 Annual and transition report of foreign private is 4D制药ADR资讯 04-02 18:20
568 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-01 19:25
555 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 03-23 03:21
511 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-19 02:13
590 0 公告 Certification by an exchange approving securities 4D制药ADR资讯 03-18 22:13
470 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-18 05:03
492 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-17 21:54
490 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 03-09 05:35
619 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-01 21:00
539 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-01 21:00
545 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-26 21:41
530 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-26 21:34
509 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-26 21:28
528 0 公告 Notice of Effectiveness 4D制药ADR资讯 02-26 20:26
558 0 公告 Notice of Effectiveness 4D制药ADR资讯 02-26 20:15
651 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-25 06:59
377 0 公告 SEC Staff Letter: REDACTED EXHIBIT 4D制药ADR资讯 02-25 00:00
481 0 公告 Registration of securities [Section 12(b)] 4D制药ADR资讯 02-24 07:45
486 0 公告 [Cover]Correspondence 4D制药ADR资讯 02-24 00:00
433 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-19 00:00
412 0 公告 Registration of American Depository Receipt shares 4D制药ADR资讯 02-18 00:00
403 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-16 00:00
400 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-08 00:00
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
郑重声明:用户在社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-34289898 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500